|
|
|
|
||
|
||
|
Vol. 7, Nos. 1-43, pp. 1-1268 Jan. 2 -- Oct. 30, 2009 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Kaiser Found. Health Plan Inc. v. Abbott Labs. (9th Cir.), 91
Kansas v. Kloxin (Kan. Dist. Ct.), 617 Kappos; Tafas v. (Fed. Cir.), 1224 K-Dur Antitrust Litig., In re (D.N.J.), 38; 175 Kellogg v. Wyeth (D. Vt.), 6; 465 Kelly v. Teva Pharms. Indus. Ltd. (Cal. Super. Ct.), 706 Kennedy; Montana Bd. of Pharmacy v. (Mont. Dist. Ct.), 154 Kennedy, U.S. ex rel. v. Aventis Pharms. Inc. (N.D. Ill.), 501 Kentucky v. AstraZeneca (Ky. Cir. Ct.), 1222 Kieff, U.S. ex rel. v. Wyeth (D. Mass.), 582 Kilker v. SmithKline Beecham Corp. (Pa. Ct. Com. Pl.), 1197 Kilpatrick v. Breg Inc. (S.D. Fla.), 827 King Pharms. Inc. v. Eon Labs Inc. (E.D.N.Y.), 92 King Pharms. Inc. v. Sandoz Inc. (D.N.J.), 1071 Kleinman v. Merck & Co. (N.J. Super. Ct.), 340 Kloxin; Kansas v. (Kan. Dist. Ct.), 617 Kumar v. Blue Cross of Cal. Inc. (Cal. Super. Ct.), 296 KV Pharm. Co.; Stiefel Labs. Inc. v. (D. Del.), 640 KV Pharm. Co.; U.S. v. (E.D. Mo.), 251 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
